γ-Cyclodextrin enhances the biopharmaceutical performance of Boswellia serrata extract: comparative in vitro and ex vivo evaluation
Year: 2026
Type: article
Abstract: Poor oral bioavailability of boswellic acids (BAs) restricts the therapeutic potential of Boswellia serrata extracts (BSE), primarily due to low solubility and limited intestinal absorption. This study systematically evaluated cyclodextrin (CD)-based BSE formulations to identify a composition with the potential to enhance the biopharmaceutical performance of BAs. Native and substituted CDs were screened for BA solubilization. Selected BSE formulations were prepared by lyophilization and physical mixing and characterized using HPLC, FT-IR, PXRD and DSC. Dissolution was evaluated in fasted- and fed-state biorelevant media, followed by intestinal parallel artificial membrane permeability assay (PAMPA) and ex vivo porcine intestinal permeation studies. The greatest solubility enhancements were provided by γ-CDs. Lyophilizates markedly enhanced BA dissolution, with approximately 8–10-fold higher release in fasted-state medium and complete release in fed-state medium. In PAMPA, HP-γ-CD increased apparent BA permeability by up to 3–5-fold in fasted-state medium, versus 1.7–2.8-fold for native γ-CD. Conversely, ex vivo studies identified native γ-CD as the superior carrier, increasing cumulative BA permeation approximately 15-fold. The superior performance of γ-CDs is consistent with the hypothesis that their larger cavity provides favorable accommodation of bulky BAs. The contrasting PAMPA and ex vivo outcomes indicate that biopharmaceutical performance depends on the balance between solubilization, free-drug availability and membrane interactions rather than solubilization capacity alone. Native γ-CD demonstrated the most favorable overall performance, particularly in the ex vivo permeation model, supporting further evaluation of its potential to improve intestinal absorption of BAs.
Source: Figshare
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7236408234
